Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity

Cell Metabolism

Volumn 12, Issue 2, 2010, Pages 154-165

  Li, Jia ^a,b   Romestaing, Caroline ^a   Han, Xianlin ^c   Li, Yuan ^a   Hao, Xinbao ^a   Wu, Yinyuan ^d   Sun, Chao ^a   Liu, Xiaolei ^a   Jefferson, Leonard S ^a   Xiong, Jingwei ^e   Lanoue, Kathryn F ^a   Chang, Zhijie ^d   Lynch, Christopher J ^a   Wang, Huayan ^b   Shi, Yuguang ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NORTHWEST A F UNIVERSITY   (China)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Tsinghua University ^*  (China)

^e PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ALCAT1 PROTEIN; CARDIOLIPIN; INSULIN; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; INSULIN RESISTANCE; LIPID OXIDATION; MITOCHONDRION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 78049407128     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2010.07.003     Document Type: Article

References (54)

1. Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C. T., Price, J. W., III, Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009). Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 119, 573-581. Published online February 2, 2009. 10.1172/JCI37048.
2. Asmann, Y. W., Stump, C. S., Short, K. R., Coenen-Schimke, J. M., Guo, Z., Bigelow, M. L., and Nair, K. S. (2006). Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 55, 3309-3319. (Pubitemid 44923587)
3. Bagi, Z., Koller, A., and Kaley, G. (2004). PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 286, H742-H748. (Pubitemid 38140357)
4. Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., and Olefsky, J. M. (2006). Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55, 2277-2285. (Pubitemid 44743625)
5. Block, K., Gorin, Y., and Abboud, H. E. (2009). Subcellular localization of Nox4 and regulation in diabetes. Proc. Natl. Acad. Sci. USA 106, 14385-14390.
6. Bonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., and Rieusset, J. (2008). Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest. 118, 789-800. (Pubitemid 351206566)
7. Boudina, S., Sena, S., Theobald, H., Sheng, X., Wright, J. J., Hu, X. X., Aziz, S., Johnson, J. I., Bugger, H., Zaha, V. G., and Abel, E. D. (2007). Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56, 2457-2466. (Pubitemid 47523253)
8. Cao, J., Liu, Y., Lockwood, J., Burn, P., and Shi, Y. (2004). A novel cardiolipinremodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J. Biol. Chem. 279, 31727-31734. (Pubitemid 39037844)
9. Cao, J., Shen, W., Chang, Z., and Shi, Y. (2009). ALCAT1 is apolyglycerophospholipid acyltransferase potently regulated by adenine nucleotide and thyroid status. Am. J. Physiol. Endocrinol. Metab. 296, E647-E653.
10. Chen, S., He, Q., and Greenberg, M. L. (2008). Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth. Mol. Microbiol. 68, 1061-1072. (Pubitemid 351581071)
11. Chicco, A. J., and Sparagna, G. C. (2007). Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am. J. Physiol. Cell Physiol. 292, C33-C44. (Pubitemid 46115119)
12. den Boer, M. E., Dionisi-Vici, C., Chakrapani, A., van Thuijl, A. O., Wanders, R. J., and Wijburg, F. A. (2003). Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J. Pediatr. 142, 684-689. (Pubitemid 36737173)
13. Gredilla, R., López Torres, M., Portero-Otín, M., Pamplona, R., and Barja, G. (2001). Influence of hyper-and hypothyroidism on lipid peroxidation, unsaturation of phospholipids, glutathione system and oxidative damage to nuclear and mitochondrial DNA in mice skeletal muscle. Mol. Cell. Biochem. 221, 41-48. (Pubitemid 33640558)
14. Han, X., Yang, J., Cheng, H., Yang, K., Abendschein, D. R., and Gross, R. W. (2005). Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 44, 16684-16694. (Pubitemid 41832048)
15. Han, X., Yang, J., Yang, K., Zhao, Z., Abendschein, D. R., and Gross, R. W. (2007). Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry 46, 6417-6428. (Pubitemid 46842885)
16. Hong, M. Y., Chapkin, R. S., Barhoumi, R., Burghardt, R. C., Turner, N. D., Henderson, C. E., Sanders, L. M., Fan, Y. Y., Davidson, L. A., Murphy, M. E., et al. (2002). Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis 23, 1919-1925. (Pubitemid 35355941)
17. Houstis, N., Rosen, E. D., and Lander, E. S. (2006). Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948.
18. Ibdah, J. A., Perlegas, P., Zhao, Y., Angdisen, J., Borgerink, H., Shadoan, M. K., Wagner, J. D., Matern, D., Rinaldo, P., and Cline, J. M. (2005). Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 128, 1381-1390. (Pubitemid 40712187)
19. Jiang, F., Ryan, M. T., Schlame, M., Zhao, M., Gu, Z., Klingenberg, M., Pfanner, N., and Greenberg, M. L. (2000). Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J. Biol. Chem. 275, 22387-22394. (Pubitemid 30621825)
20. Kagan, V. E., Tyurin, V. A., Jiang, J., Tyurina, Y. Y., Ritov, V. B., Amoscato, A. A., Osipov, A. N., Belikova, N. A., Kapralov, A. A., Kini, V., et al. (2005). Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 1, 223-232.
21. Kokoszka, J. E., Coskun, P., Esposito, L. A., and Wallace, D. C. (2001). Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc. Natl. Acad. Sci. USA 98, 2278-2283. (Pubitemid 32209473)
22. Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008). Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45-56.
23. Lowell, B. B., and Shulman, G. I. (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387. (Pubitemid 40139974)
24. Mahadev, K., Motoshima, H., Wu, X., Ruddy, J. M., Arnold, R. S., Cheng, G., Lambeth, J. D., and Goldstein, B. J. (2004). The NAD (P) H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24, 1844-1854. (Pubitemid 38248927)
25. Meigs, J. B., Larson, M. G., Fox, C. S., Keaney, J. F., Jr., Vasan, R. S., and Benjamin, E. J. (2007). Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 30, 2529-2535. (Pubitemid 47547788)
26. Mootha, V. K., Handschin, C., Arlow, D., Xie, X., St Pierre, J., Sihag, S., Yang, W., Altshuler, D., Puigserver, P., Patterson, N., et al. (2004). Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. USA 101, 6570-6575. (Pubitemid 38586015)
27. Nair, K. S., Bigelow, M. L., Asmann, Y. W., Chow, L. S., Coenen-Schimke, J. M., Klaus, K. A., Guo, Z.-K., Sreekumar, R., and Irving, B. A. (2008). Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57, 1166-1175.
28. Ng, Y., Barhoumi, R., Tjalkens, R. B., Fan, Y. Y., Kolar, S., Wang, N., Lupton, J. R., and Chapkin, R. S. (2005). The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis 26, 1914-1921. (Pubitemid 41631264)
29. Olusi, S. O. (2002). Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int. J. Obes. Relat. Metab. Disord. 26, 1159-1164.
30. Pan, H. J., Lin, Y., Chen, Y. E., Vance, D. E., and Leiter, E. H. (2006). Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism. Vascul. Pharmacol. 45, 65-71. (Pubitemid 43963486)
31. Paradies, G., Petrosillo, G., Pistolese, M., and Ruggiero, F. M. (2002). Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 286, 135-141. (Pubitemid 34273870)
32. Paradies, G., Petrosillo, G., Pistolese, M., Di Venosa, N., Federici, A., and Ruggiero, F. M. (2004). Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ. Res. 94, 53-59. (Pubitemid 38064098)
33. Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., and Shulman, G. I. (2004). Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664-671. (Pubitemid 38364625)
34. Petersen, K. F., Dufour, S., and Shulman, G. I. (2005). Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med. 2, e233.
35. Pospisilik, J. A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P. D., Ebersberger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007). Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131, 476-491. (Pubitemid 350017761)
36. Quintanilla, R. A., Jin, Y. N., Fuenzalida, K., Bronfman, M., and Johnson, G. V. (2008). Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease. J. Biol. Chem. 283, 25628-25637.
37. Schlame, M., Rua, D., and Greenberg, M. L. (2000). The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39, 257-288. (Pubitemid 30224706)
38. Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005). Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909-1911. (Pubitemid 40941874)
39. Short, K. R., Nygren, J., and Nair, K. S. (2007). Effect of T (3)-induced hyperthyroidism on mitochondrial and cytoplasmic protein synthesis rates in oxidative and glycolytic tissues in rats. Am. J. Physiol. Endocrinol. Metab. 292, E642-E647. (Pubitemid 46220591)
40. Sparagna, G. C., and Lesnefsky, E. J. (2009). Cardiolipin remodeling in the heart. J. Cardiovasc. Pharmacol. 53, 290-301.
41. Sparagna, G. C., Chicco, A. J., Murphy, R. C., Bristow, M. R., Johnson, C. A., Rees, M. L., Maxey, M. L., McCune, S. A., and Moore, R. L. (2007). Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J. Lipid Res. 48, 1559-1570. (Pubitemid 47312017)
42. Stone, S. J., Levin, M. C., Zhou, P., Han, J., Walther, T. C., and Farese, R. V., Jr. (2009). The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria. J. Biol. Chem. 284, 5352-5361.
43. Taylor, W. A., and Hatch, G. M. (2003). Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J. Biol. Chem. 278, 12716-12721. (Pubitemid 36800033)
44. Taylor, W. A., and Hatch, G. M. (2009). Identification ofthe human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1). J. Biol. Chem. 284, 30360-30371.
45. Tirosh, A., Potashnik, R., Bashan, N., and Rudich, A. (1999). Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J. Biol. Chem. 274, 10595-10602.
46. Tonin, A. M., Grings, M., Busanello, E. N., Moura, A. P., Ferreira, G. C., Viegas, C. M., Fernandes, C. G., Schuck, P. F., and Wajner, M. (2010). Long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies induce oxidative stress in rat brain. Neurochem. Int. 56, 930-936.
47. Turner, N., and Heilbronn, L. K. (2008). Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol. Metab. 19, 324-330.
48. Van, Q., Liu, J., Lu, B., Feingold, K. R., Shi, Y., Lee, R. M., and Hatch, G. M. (2007). Phospholipid scramblase-3 regulates cardiolipin de novo biosynthesis and its resynthesis in growing HeLa cells. Biochem. J. 401, 103-109. (Pubitemid 46114604)
49. Voynow, J. A., Fischer, B. M., Zheng, S., Potts, E. N., Grover, A. R., Jaiswal, A. K., Ghio, A. J., and Foster, W. M. (2009). NAD (P) H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans. Am. J. Respir. Cell Mol. Biol. 41, 107-113.
50. Watkins, S. M., Carter, L. C., and German, J. B. (1998). Docosahexaenoic acid accumulates in cardiolipin and enhances HT-29 cell oxidant production. J. Lipid Res. 39, 1583-1588. (Pubitemid 28377921)
51. Watkins, S. M., Reifsnyder, P. R., Pan, H. J., German, J. B., and Leiter, E. H. (2002). Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43, 1809-1817. (Pubitemid 35315798)
52. Wilson-Fritch, L., Burkart, A., Bell, G., Mendelson, K., Leszyk, J., Nicoloro, S., Czech, M., and Corvera, S. (2003). Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 23, 1085-1094. (Pubitemid 36133524)
53. Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., Straubhaar, J., Czech, M. P., and Corvera, S. (2004). Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114, 1281-1289. (Pubitemid 40385299)
54. Xu, Y., Kelley, R. I., Blanck, T. J. J., and Schlame, M. (2003). Remodeling of cardiolipin by phospholipid transacylation. J. Biol. Chem. 278, 51380-51385. (Pubitemid 38020377)